The CyberKnife is the world’s first and only commercial application of robotic stereotactic radiosurgery for tumors and lesions throughout the body. It offers important cancer-treatment options, especially for patients with inoperable or surgically complex tumors, or those who seek an alternative to conventional surgery or radiation therapy. Because treatment with CyberKnife does not require incisions or anesthesia, there is also much less risk for complications than conventional surgery.
CyberKnife offers several benefits for patients, particularly in regards to quality of life issues that may be dramatically impacted by conventional surgery.
Key advantages of CyberKnife: